Approval of Libervant marks the first orally administered rescue medication for this age group to be cleared by the FDA for epilepsy.
![FDA Approves Aquestive Therapeutics’ Libervant for the Treatment of Seizure Clusters in Children Aged 2 to 5 Years](https://onclive.s3.amazonaws.com/onclive_630x1200.png)
Approval of Libervant marks the first orally administered rescue medication for this age group to be cleared by the FDA for epilepsy.